QuickLinks-- Click here to rapidly navigate through this document

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)

15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTER ENDED SEPTEMBER 30, 2001MARCH 31, 2002

Commission file number 0-16244



VEECO INSTRUMENTS INCINC.
.

(Exact name of registrant as specified in its charter)

Delaware

11-2989601


(State or other jurisdiction of
incorporation or organization)

11-2989601
(I.R.S. Employer
Identification Number)


100 Sunnyside Boulevard

11797


Woodbury, NYNew York

(zip code)


(Address of principal executive offices)



(516) 677-020011797

Registrant’s telephone number, including area code


(Zip Code)

Registrant's telephone number, including area code:(516) 677-0200


Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days:

Yes ý No o

28,738,68729,043,674 shares of common stock, $0.01 par value per share, were outstanding as of the close of business on November 2, 2001.April 23, 2002.





SAFE HARBOR STATEMENT

        

This Quarterly Report on Form 10-Q (the “Report”"Report") contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Discussions containing such forward-looking statements may be found in Items 2 and 3 of Part I hereof, as well as within this Report generally. In addition, when used in this Report, the words “believes,” “anticipates,” “expects,” “estimates,” “plans,” “intends,”"believes," "anticipates," "expects," "estimates," "plans," "intends," and similar expressions are intended to identify forward-looking statements. All forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from projected results. Factors that may cause these differences include, but are not limited to:

    the dependence on principal customers and the cyclical nature of the data storage, semiconductor and optical and wireless telecommunications and semiconductor industries,



    fluctuations in quarterly operating results,



    rapid technological change and risks associated with the acceptance of new products by individual customers and by the marketplace,



    risk of cancellation or rescheduling of orders,



    the highly competitive nature of industries in which the Company operates,



    changes in foreign currency exchange rates, and



    the risk factors and other matters discussed in the Business Description contained in the Company’sCompany's Annual Report on Form 10-K for the year ended December 31, 2000.

    2001.

Consequently, such forward-looking statements should be regarded solely as the Company’sCompany's current plans, estimates and beliefs. The Company does not undertake any obligation to update any forward-lookingforward- looking statements to reflect future events or circumstances after the date of such statements.

2



VEECO INSTRUMENTS INC. AND SUBSIDIARIES

INDEX

INDEX



Page

Part I.PART 1. FINANCIAL INFORMATION

Financial Information


Item 1.



Financial Statements (Unaudited):






Condensed Consolidated Statements of Operations — Operations—
Three Months Ended September 30,March 31, 2002 and 2001 and 2000



4



Condensed Consolidated Statements of Operations — Nine Months Ended September 30, 2001 and 2000


Condensed Consolidated Balance Sheets — September 30, 2001Sheets—
March 31, 2002 and December 31, 2000

2001


5




Condensed Consolidated Statements of Cash Flows — NineFlows—
Three Months Ended September 30,March 31, 2002 and 2001 and 2000



6




Notes to Condensed Consolidated Financial Statements



7


Item 2.

Item 2


Management’s
Management's Discussion and Analysis of Financial Condition and Results of Operations



10


Item 3.



Quantitative and Qualitative Disclosure About Market Risk



14


PART II. OTHER INFORMATION



Part II.

Other Information

Item 1.

Legal Proceedings


Item 6.



Exhibits and Reports on Form 8-K



15


SIGNATURES

SIGNATURES



16

3



PartPART I. Financial InformationFINANCIAL INFORMATION

Item 1. Financial Statements (Unaudited)


Veeco Instruments Inc. and Subsidiaries


Condensed Consolidated Statements of Operations


(In thousands, except per share data)
(Unaudited)

 
 Three Months Ended March 31,
 
 
 2002
 2001
 
Net sales $80,149 $125,386 
Cost of sales  46,414  66,696 
  
 
 
Gross profit  33,735  58,690 

Costs and expenses:

 

 

 

 

 

 

 
 Research and development expense  13,329  15,107 
 Selling, general and administrative expense  19,037  21,134 
 Amortization expense  3,747  1,436 
 Other expense, net  49  1,406 
 Restructuring expense  837   
  
 
 
Operating (loss) income  (3,264) 19,607 
Interest expense (income), net  1,486  (767)
  
 
 
(Loss) income from continuing operations before income taxes  (4,750) 20,374 
Income tax (benefit) provision  (1,598) 7,158 
  
 
 
(Loss) income from continuing operations  (3,152) 13,216 
Discontinued operations:       
 Loss from discontinued operations, net of taxes    (343)
 Loss on the disposal of discontinued operations, net of taxes  (346)  
  
 
 
Net (loss) income $(3,498)$12,873 
  
 
 
(Loss) earnings per common share:       

Net (loss) income per common share from continuing operations

 

$

(0.11

)

$

0.54

 
Loss from discontinued operations  (0.01) (0.02)
  
 
 
Net (loss) income per common share $(0.12)$0.52 
  
 
 
Diluted (loss) income per common share from continuing operations $(0.11)$0.52 
Loss from discontinued operations  (0.01) (0.01)
  
 
 
Diluted net (loss) income per common share $(0.12)$0.51 
  
 
 
Weighted average shares outstanding  29,021  24,678 
Diluted weighted average shares outstanding  29,021  25,230 

See accompanying notes.

4


(Unaudited)

 

 

Three Months Ended

 

 

 

September 30,

 

 

 

2001

 

2000

 

Net sales

 

$

115,951

 

$

81,146

 

Cost of sales

 

65,115

 

43,805

 

Gross profit

 

50,836

 

37,341

 

 

 

 

 

 

 

Costs and expenses:

 

 

 

 

 

Research and development expense

 

15,414

 

13,115

 

Selling, general and administrative expense

 

21,348

 

20,164

 

Amortization expense

 

1,039

 

1,180

 

Other expense, net

 

765

 

496

 

Write-off of purchased in-process technology

 

8,200

 

-

 

Operating income

 

4,070

 

2,386

 

Interest income, net

 

(263

)

(407

)

Income before income taxes

 

4,333

 

2,793

 

Income tax provision (benefit)

 

2,485

 

(392

)

Net income

 

$

1,848

 

$

3,185

 

 

 

 

 

 

 

Net income per common share

 

$

0.07

 

$

0.13

 

Diluted net income per common share

 

$

0.07

 

$

0.12

 

 

 

 

 

 

 

Weighted average shares outstanding

 

25,413

 

24,098

 

 

 

 

 

 

 

Diluted weighted average shares outstanding

 

25,669

 

25,561

 

See Accompanying Notes.


Veeco Instruments Inc. and Subsidiaries


Condensed Consolidated Statements of Operations

Balance Sheets
(In thousands, except per share data)thousands)

 
 March 31,
2002

 December 31,
2001

 
 (Unaudited)

  
Assets      
Current Assets:      
Cash and cash equivalents $219,108 $203,154
Accounts receivable, net  69,815  88,449
Inventories  99,273  101,419
Prepaid expenses and other current assets  15,611  22,636
Deferred income taxes  49,549  46,832
  
 
Total current assets  453,356  462,490

Property, plant and equipment at cost, net

 

 

76,699

 

 

78,547
Goodwill  125,585  125,585
Long-term investments  34,912  23,519
Other assets, net  63,054  65,378
  
 
Total assets $753,606 $755,519
  
 
Liabilities and shareholders' equity      
Current Liabilities:      
Accounts payable  19,809  19,657
Accrued expenses  49,163  58,070
Deferred gross profit  9,265  14,566
Other current liabilities  7,875  12,174
  
 
Total current liabilities  86,112  104,467

Long-term debt, net of current portion

 

 

235,156

 

 

215,519
Other non-current liabilities  11,932  11,562
Shareholders' equity  420,406  423,971
  
 
Total liabilities and shareholders' equity $753,606 $755,519
  
 

See accompanying notes.

5


(Unaudited)

 

 

Nine Months Ended

 

 

 

 

September 30,

 

 

 

 

2001

 

2000

 

 

Net sales

 

$

356,674

 

$

270,301

 

 

Cost of sales

 

193,050

 

163,597

 

 

Gross profit

 

163,624

 

106,704

 

 

Costs and expenses:

 

 

 

 

 

 

Research and development expense

 

46,530

 

40,523

 

 

Selling, general and administrative expense

 

64,327

 

56,450

 

 

Amortization expense

 

3,356

 

2,665

 

 

Other expense, net

 

2,397

 

537

 

 

Merger and restructuring expense

 

1,000

 

14,206

 

 

Write-off of purchased in-process technology

 

8,200

 

-

 

 

Asset impairment charge

 

-

 

3,722

 

 

Operating income (loss)

 

37,814

 

(11,399

)

 

Interest income, net

 

(1,426

)

(928

)

 

Income (loss) before income taxes

 

39,240

 

(10,471

)

 

Income tax provision (benefit)

 

14,519

 

(5,578

)

 

Net income (loss) before cumulative effect of change in accounting principle

 

24,721

 

(4,893

)

Cumulative effect of change in accounting principle, net of taxes

 

-

 

(18,382

)

 

Net income (loss)

 

$

24,721

 

$

(23,275

)

 

 

 

 

 

 

 

 

Net income (loss) per common share before cumulative effect of change in accounting principle

 

$

0.99

 

$

(0.21

)

 

Cumulative effect of change in accounting principle

 

-

 

(0.78

)

 

Net income (loss) per common share

 

$

0.99

 

$

(0.99

)

 

Diluted net income (loss) per common share before cumulative effect of change in accounting principle

 

$

0.97

 

$

(0.21

)

Cumulative effect of change in accounting principle

 

-

 

(0.78

)

 

Diluted net income (loss) per common share

 

$

0.97

 

$

(0.99

)

 

 

 

 

 

 

 

 

Weighted average shares outstanding

 

24,956

 

23,537

 

 

 

 

 

 

 

 

 

Diluted weighted average shares outstanding

 

25,373

 

23,537

 

 

See Accompanying Notes.


Veeco Instruments Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(In thousands)

 

 

September 30,

 

December 31,

 

 

 

2001

 

2000

 

 

 

(Unaudited)

 

 

 

Assets

 

 

 

 

 

Current Assets:

 

 

 

 

 

Cash and cash equivalents

 

$

55,160

 

$

63,420

 

Short-term investments

 

-

 

26,895

 

Accounts receivable, net

 

94,001

 

98,248

 

Inventories

 

142,202

 

100,062

 

Prepaid expenses and other current assets

 

10,812

 

8,307

 

Deferred income taxes

 

41,399

 

45,303

 

Total current assets

 

343,574

 

342,235

 

 

 

 

 

 

 

Property, plant and equipment at cost, net

 

75,493

 

60,094

 

Excess of cost over net assets acquired, net

 

129,871

 

9,481

 

Intangible assets, net

 

64,223

 

6,315

 

Other non-current assets, net

 

1,088

 

5,158

 

Total assets

 

$

614,249

 

$

423,283

 

 

 

 

 

 

 

Liabilities and Shareholders’ Equity

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

Accounts payable

 

$

25,536

 

$

33,134

 

Accrued expenses

 

63,786

 

56,093

 

Deferred gross profit

 

14,489

 

28,771

 

Other current liabilities

 

10,143

 

3,774

 

Total current liabilities

 

113,954

 

121,772

 

 

 

 

 

 

 

Long-term debt, net of current portion

 

38,055

 

14,631

 

Deferred income taxes

 

28,020

 

2,681

 

Other non-current liabilities

 

1,287

 

1,291

 

Shareholders’ equity

 

432,933

 

282,908

 

Total liabilities and shareholders’ equity

 

$

614,249

 

$

423,283

 

See Accompanying Notes.


Veeco Instruments Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows


(In thousands)
(Unaudited)

 
 Three Months Ended March 31,
 
 
 2002
 2001
 
Net cash provided by operating activities $1,783 $2,049 

Investing Activities

 

 

 

 

 

 

 
Capital expenditures  (2,078) (4,451)
Payment for net assets of businesses acquired    (1,791)
Net purchases of short-term investments    (391)
Net purchases of long-term investments  (2,387)  
  
 
 
Net cash used in investing activities  (4,465) (6,633)

Financing Activities

 

 

 

 

 

 

 
Proceeds from stock issuance  255  272 
Repayment of long-term debt, net  (449) (507)
Proceeds from issuance of long-term debt  20,000   
Payment for debt issuance costs  (1,185)  
  
 
 
Net cash provided by (used in) financing activities  18,621  (235)
Effect of exchange rates on cash and cash equivalents  15  2,253 
  
 
 
Net change in cash and cash equivalents  15,954  (2,566)
Cash and cash equivalents at beginning of period  203,154  63,419 
  
 
 
Cash and cash equivalents at end of period $219,108 $60,853 
  
 
 

See accompanying notes.

6


(Unaudited)

 

 

Nine Months Ended

 

 

 

September 30,

 

 

 

2001

 

2000

 

 

 

 

 

 

 

Net cash provided by operating activities

 

$

13,428

 

$

6,835

 

 

 

 

 

 

 

Investing Activities

 

 

 

 

 

Capital expenditures

 

(10,975

)

(14,140

)

Payment for net assets of businesses acquired

 

(59,557

)

(11,433

)

Net sales/(purchases) of short-term investments

 

26,896

 

(2,058

)

Proceeds from sale of business

 

-

 

3,000

 

Other, net

 

11

 

(33

)

Net cash used in investing activities

 

(43,625

)

(24,664

)

 

 

 

 

 

 

Financing Activities

 

 

 

 

 

Proceeds from stock issuance

 

3,002

 

26,628

 

Repayment of long-term debt, net

 

(7,721

)

(8,992

)

Net proceeds from borrowings under line of credit

 

25,000

 

17,240

 

Financing activities three months ended 12/31/99 – CVC

 

-

 

3,627

 

Net cash provided by financing activities

 

20,281

 

38,503

 

Effect of exchange rates on cash and cash equivalents

 

1,656

 

1,116

 

Net change in cash and cash equivalents

 

(8,260

)

21,790

 

Cash and cash equivalents at beginning of period

 

63,420

 

29,852

 

Cash and cash equivalents at end of period

 

$

55,160

 

$

51,642

 

See Accompanying Notes.VEECO INSTRUMENTS INC. AND SUBSIDIARIES


Veeco Instruments Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited)

Note 1 — 1—Basis of Presentation

        

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation (consisting of normal recurring accruals) have been included. Operating results for the ninethree months ended September 30, 2001March 31, 2002 are not necessarily indicative of the results that may be expected for the year ending December 31, 2001.2002. For further information, refer to the financial statements and footnotes thereto included in the Company’sCompany's Annual Report on
Form 10-K for the year ended December 31, 2000.2001.

        

Earnings per share are computed using the weighted average number of common shares outstanding during the period. Diluted earnings per share are computed using the weighted average number of common and common equivalent shares outstanding during the period. The effect of common equivalent shares for the ninethree months ended September 30, 2000March 31, 2002 was antidilutive, and therefore was excluded from the diluted weighted average shares outstanding.earnings per share is not presented for such period.

        

The following table sets forth the reconciliation of diluted weighted average shares outstanding:

 
 Three Months Ended March 31,
 
 2002
 2001
 
 (In thousands)

Weighted average shares outstanding 29,021 24,678
Dilutive effect of stock options  552
  
 
Diluted weighted average shares outstanding 29,021 25,230
  
 

        In addition, the assumed conversion of subordinated convertible notes is anti-dilutive for the three months ended March 31, 2002 and therefore is not included in the above diluted weighted average shares outstanding.

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

September 30,

 

September 30,

 

 

 

2001

 

2000

 

2001

 

2000

 

 

 

(In Thousands)

 

(In Thousands)

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding

 

25,413

 

24,098

 

24,956

 

23,537

 

Dilutive effect of stock options and warrants

 

256

 

1,463

 

417

 

 

Diluted weighted average shares outstanding

 

25,669

 

25,561

 

25,373

 

23,537

 


Note 2 — 2—Balance Sheet Information

Inventories

        

Short-Term Investments

The carrying amounts of available-for-sale securities approximate fair value. The following is a summary of available-for-sale securities:

 

 

September 30,

 

December 31,

 

 

 

2001

 

2000

 

 

 

(In thousands)

 

Commercial paper

 

$

-

 

$

15,730

 

Obligations of U.S. Government agencies

 

-

 

4,404

 

Other debt securities

 

-

 

4,054

 

Municipal bonds

 

-

 

2,707

 

 

 

$

-

 

$

26,895

 

As of September 30, 2001, the Company had sold all of its available-for-sale securities, which had fair values at the dates of sale of approximately $67.9 million.  The cash generated from the sale of these securities was used for acquisitions and general corporate purposes.

Inventories

Interim inventories have been determined by lower of cost (principally first-in, first-out) or market. Inventories consist of:

 
 March 31, 2002
 December 31, 2001
 
 (In thousands)

Raw materials $56,128 $59,065
Work-in-progress  22,318  26,068
Finished goods  20,827  16,286
  
 
  $99,273 $101,419
  
 

7

 

 

September 30,

 

December 31,

 

 

 

2001

 

2000

 

 

 

(In thousands)

 

Raw materials

 

$

74,035

 

$

60,281

 

Work-in-progress

 

41,805

 

23,703

 

Finished goods

 

26,362

 

16,078

 

 

 

$

142,202

 

$

100,062

 


Other Balance Sheet Information

 

September 30,

 

December 31,

 

 

2001

 

2000

 

 March 31, 2002
 December 31, 2001

 

(In thousands)

 

 (In thousands)

Allowance for doubtful accounts

 

$

2,206

 

$

2,116

 

 $3,253 $3,350

Accumulated depreciation and amortization of property, plant and equipment

 

$

51,125

 

 

$

38,801

 

 $58,110 $54,826
Accumulated amortization of intangible assets $16,926 $13,179


Note 3 — 3—Segment Information

        

The following represents the reportable product segments of the Company as of and for the three months ended March 31, 2002 and 2001, in thousands:

 
 Net Sales
 Income (loss) before interest, taxes and amortization
 Total Assets
 
 2002
 2001
 2002
 2001
 2002
 2001
Process Equipment $44,852 $80,297 $(1,856)$16,302 $308,567 $180,653
Metrology  35,297  45,089  5,121  7,349  136,753  106,441
Restructuring expense      (837)     
Unallocated Corporate amount      (1,945) (2,608) 308,286  159,809
  
 
 
 
 
 
Total $80,149 $125,386 $483 $21,043 $753,606 $446,903
  
 
 
 
 
 

 

 

Process Equipment

 

Metrology

 

Industrial Measurement

 

Unallocated Corporate Amount

 

Non-recurring Charges

 

Total

 

Three Months Ended September 30, 2001

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

65,887

 

$

48,389

 

$

1,675

 

$

 

$

 

$

115,951

 

Operating income (loss)

 

7,443

 

7,685

 

(591

)

(2,267

)

(8,200

)

4,070

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30, 2000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

38,819

 

39,753

 

2,574

 

 

 

81,146

 

Operating income (loss)

 

(875

)

7,487

 

(1,368

)

(2,858

)

__

 

2,386

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended September 30, 2001

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

219,429

 

132,326

 

4,919

 

 

 

356,674

 

Operating income (loss)

 

35,653

 

20,070

 

(1,972

)

(6,737

)

(9,200

)

37,814

 

Total assets

 

354,357

 

135,858

 

6,860

 

117,174

 

__

 

614,249

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended September 30, 2000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

151,706

 

110,486

 

8,109

 

 

 

270,301

 

Operating income (loss)

 

10,376

 

19,315

 

(2,308

)

(5,532

)

(33,250

)

(11,399

)

Total assets

 

$

150,658

 

$

96,038

 

$

11,163

 

$

163,888

 

$

 

$

421,747

 

Note 4 — 4—Comprehensive Income (Loss)

        

Total comprehensive (loss) income (loss) was $3.0($3.9) million and $24.7$12.0 million for the three and nine months ended September 30,March 31, 2002 and 2001, respectively, and $2.6 million and ($24.6) million for the three and nine months ended September 30, 2000, respectively. Other comprehensive income is comprised of foreign currency translation adjustments, minimum pension liability and net unrealized holding gains and losses on available-for-sale securities.


Note 5 — 5—Recent EventsAccounting Pronouncements

Acquisition of Applied Epi, Inc.

On September 17, 2001, a wholly owned subsidiary of        Effective January 1, 2002, the Company merged with and into Applied Epi, Inc. (“Applied Epi”), of St. Paul, Minnesota.  As a result of the merger, Applied Epi became a subsidiary of the Company.  Applied Epi provides molecular beam epitaxy (“MBE”) equipment used in manufacturing high-speed compound semiconductor devices for telecommunications, optoelectronic and wireless markets.  Applied Epi, founded in 1986, was a privately held company. Under the merger agreement, the stockholders of Applied Epi received an aggregate of 3,883,460 shares of Veeco common stock and $29.8 million in cash.  In addition, the Company incurred acquisition costs and exchanged and assumed options and warrants of Applied Epi for options and warrants to purchase 1,021,248 shares of the Company’s common stock.  The assumed options and warrants were recorded at fair market value using the Black-Scholes option-pricing model.  The merger consideration is computed as follows (in thousands):

Fair market value of shares issued

 

$

101,040

 

Cash payment

 

29,800

 

Fair market of stock options/warrants assumed

 

19,223

 

Transaction costs

 

2,905

 

Total purchase price

 

$

152,968

 

The merger was accounted for using the purchase method of accounting.  Accordingly, the purchase price was allocated to the net assets acquired, based upon their estimated fair values, as determined by an independent appraisal as follows (in thousands):

Accounts receivable, net

 

$

12,389

 

Inventories

 

11,966

 

Other current assets

 

418

 

Property, plant and equipment, net

 

12,812

 

Excess cost over net assets acquired, net

 

101,397

 

Amortizable intangible assets, net

 

48,500

 

In-process technology

 

7,000

 

Other non-current assets

 

4,830

 

Total assets

 

199,312

 

Accounts payable

 

2,139

 

Other current liabilities

 

10,582

 

Deferred income taxes

 

22,663

 

Long-term debt

 

10,960

 

Total liabilities

 

46,344

 

Total purchase price

 

$

152,968

 


The purchase price was allocated to intangible assets as follows: approximately $101.4 million to excess of cost over net assets acquired, which is non-amortizable under Statement of Financial Accounting Standards (“SFAS”)adopted SFAS No. 142,Goodwill and Other Intangible Assets; $41.0 million to core technology, amortizable over approximately six years; $1.0 million to non-compete agreements, amortizable over three years; $4.5 million to customer related intangibles, amortizable over six months to five years and$2.0 million to trademarks and trade names, amortizable over ten years.  In-process research and development (“R&D”) projects. The intangible assets that had not reached technological feasibility and had no alternative future uses totaled $7.0 million, and thus were expensedare classified as of the date of the acquisition.  The value assigned to purchased in-process R&D was determined by using the income approach, which involves estimating the discounted after-tax cash flows attributable to projects, based on the projects’ stage of completion.  The rate utilized to discount the net cash flows to their present value was 25%.

The following table represents the pro forma results of Veeco and Applied Epi, as if the combination had been consummated as of January 1, 2000:

 

 

Nine months ended

 

 

 

September 30,

 

 

 

2001

 

2000

 

 

 

(In thousands, except earnings per share)

 

Revenue

 

$

387,658

 

$

279,217

 

Income (loss) before cumulative effect of change in accounting principle

 

27,849

 

(33,120

)

Net income (loss)

 

27,849

 

(51,502

)

 

 

 

 

 

 

Net income (loss) per common share before cumulative effect of change in accounting principle

 

$

0.94

 

$

(1.16

)

Net income (loss) per common share

 

$

0.94

 

$

(1.81

)

Diluted net income (loss) per common share before cumulative effect of change in accounting principle

 

$

0.92

 

$

(1.16

)

Diluted net income (loss) per common share

 

$

0.92

 

$

(1.81

)

The results of operations for Applied Epi for the nine months ended September 30, 2001 and 2000 include non-recurring charges of $1.1 million and $18.1 million, respectively, related to stock based compensation expense.  The pro forma results of operations for the nine months ended September 30, 2000 include a $7.0 million charge related to the write-off of purchased in-process technology.

The results of operations for Applied Epi for the period from September 18, 2001 to September 30, 2001 are included in the accompanying Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2001.

Acquisition of ThermoMicroscopes Corp.

On July 16, 2001, the Company acquired ThermoMicroscopes Corp. (“TM”), formerly a subsidiary of Thermo Electron Corporation, based in Sunnyvale, California, for cash.  TM is a manufacturer of atomic force microscopes, scanning probe microscopes, near field optical microscopes and probes.  The acquisition was accounted for using the purchase method of accounting.

Results of operations prior to the acquisition are not material to the Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2001.  The results of operations for TM for the period from July 17, 2001 through September 30, 2001 are included in the accompanying Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2001.


Litigation

On August 15, 2001, a lawsuit was commenced in the Superior Court of California, County of Santa Clara, by Toyo Corporation (“Toyo”) against TM, the Company, Thermo Spectra Corporation and Thermo Electron Corporation.  This lawsuit relates to a Distribution Agreement between Toyo and TM under which Toyo had been appointed the exclusive distributor for the sale of TM products in Japan.  In the lawsuit, Toyo claims, among other things, that TM breached the Distribution Agreement and that the Company, Thermo Spectra and Thermo Electron intentionally interfered with Toyo’s contractual relationship with TM, in each case, by virtue of the sale of the outstanding shares of TM to the Company, which Toyo alleges was an assignment without Toyo’s consent.  The suit alleges damages in a currently unascertained amount.  The Company intends to vigorously defend this lawsuit and has filed a counterclaim against Toyo.  The Company does not expect this matter to have a material effect on its consolidated financial condition or results of operations.

Note 6 — Recent Accounting Pronouncements

In June 2001, the FASB issued SFAS No. 141, Business Combinations, and SFAS No. 142, Goodwill and Other Intangible Assets, effective for fiscal years beginning after December 15, 2001. Under the new rules, goodwill and other intangible assets deemed to havethose with indefinite lives willare no longer be amortized but will be subject to annual impairment tests in accordanceunder the provisions of this standard. Intangible assets with the Statements. Other intangible assetsdeterminable lives will continue to be amortized over their estimated useful lives. In addition, Statement 141 eliminateslife. The standard also requires that an impairment test be performed to support the pooling-of-interests methodcarrying value of accounting for business combinations, except for qualifying business combinations that were initiated prior to July 1, 2001.goodwill and indefinite lived intangible assets at least annually.

        The Company will apply the new rules on accounting for goodwill and other intangible assets beginning in the first quarter of 2002. Application of the non-amortization provisions of the Statement is expected to result in a decrease in amortization expense in 2002 of approximately $1.6 million. In addition, the goodwill recorded as a result of the acquisitions of Applied Epi and TM will not be amortized in 2001 in accordance with Statement 142. During 2002, the Company will performcompleted the first of the required impairment tests of goodwill and indefinite lived intangible assets in the first quarter of 2002. The Company utilized an independent appraisal as part of its evaluation process. The Company has reviewed its business and determined that four reporting units be reviewed for impairment in accordance with the standard. The four reporting units are New York Equipment and Telecommunications, which comprise the process equipment operating segment, and AFM and Optical, which comprise the metrology operating segment. Based upon the independent appraisal and the judgment of management, it was determined that there is no impairment to goodwill as of January 1, 2002.

8



        The Company has not yet determined whatfollowing table outlines the effect these standards will have oncomponents of goodwill and intangible assets by business segment at March 31, 2002 after the earnings or financial positionadoption of the Company.standard, in thousands:

 
 Process Equipment Segment
 Metrology Segment
 Unallocated Corporate
 Total
Goodwill $102,808 $22,777 $ $125,585
Intangible assets  42,210  12,606  7,325  62,141
  
 
 
 
Total $145,018 $35,383 $7,325 $187,726
  
 
 
 

        Net income for the three months ended March 31, 2001, includes approximately $0.4 million of goodwill amortization expense. Excluding this amount would have resulted in net income per common share and diluted net income per common share of $0.54 and $0.53, respectively, for the three months ended March 31, 2001.

On        In January 1, 2001,2002, the Company adopted SFAS No. 133, 144,Accounting for Derivative Instrumentsthe Impairment or Disposal of Long Lived Assets (FAS 144), which addresses financial accounting and Hedging Activities, as amended byreporting for the impairment or disposal of long-lived assets and supersedes SFAS No. 138, 121,Accounting for Certain Derivative Instrumentsthe Impairment of Long-Lived Assets and Hedging Activities — An AmendmentLong-Lived Assets to be Disposed Of, and the accounting and reporting provisions of FASBAPB Opinion No. 30,Reporting the Results of Operations for a Disposal of a Segment of a Business. Adoption of this Statement No. 133. SFAS No. 133 requires that all derivatives, including foreign currency exchange contracts, be recognizeddid not have an impact on the balance sheet at fair value, which is recorded through earnings. IfCompany's consolidated financial position or results of operations.

Note 6—Recent Events

Restructuring

        During the three months ended March 31, 2002, the Company incurred a derivative is a qualifying hedge, depending onrestructuring charge of $0.8 million related to the nature of the hedge, changesreduction in work force announced in the fair valuefourth quarter of 2001. This charge includes severance related costs for approximately 60 employees which included both management and manufacturing employees located at the derivative are either offset against the change in fair valueCompany's Minnesota, Plainview and Rochester operations. As of the underlying assets or liabilities through earnings or recognized in accumulated comprehensive income until the underlying hedged item is recognized in earnings. The ineffective portion of a derivative’s change in fair value is to be immediately recognized in earnings.March 31, 2002, approximately $0.3 million has been expended and approximately $0.5 million remains accrued.

        

During the nine monthsyear ended September 30,December 31, 2001, the Company used derivative financial instrumentsrecorded restructuring charges of approximately $20.0 million in response to minimize the impactsignificant downturn in the telecommunications industry and the overall weak business environment. These charges consisted of foreign exchange rate changesa $13.6 million write-off of inventory related to order cancellations and the rationalization of certain product lines, $3.0 million related to personnel and business relocation costs and $3.4 million related to the write-down of long-lived assets. The $3.0 million charge for personnel and business relocation costs principally related to plant consolidations and a workforce reduction of approximately 230 employees, which included both management and manufacturing employees located in all operations of the Company. As of March 31, 2002, approximately $1.7 million of the $3.0 million charge for relocation and termination benefits has been paid and approximately $1.3 million remains accrued.

Discontinued Operations

        In January 2002, Veeco signed a letter of intent to sell the remainder of its industrial measurement business. This is the measurement date of the disposal and accordingly, the Company has classified the industrial measurement business as a discontinued operation. During the three months ended March 31, 2002, the Company recorded an additional loss on earnings and cash flows. In the normal coursedisposal of business,the discontinued operations of $0.3 million, net of taxes of approximately $0.2 million. The net assets held for sale of approximately $4.0 million are exposed to fluctuationsincluded in foreign exchange rates. In order to reduce the effect of fluctuating foreign currencies on short-term foreign currency-denominated intercompany transactionsprepaid expenses and other known foreign currency exposures,current assets in the Company enters into monthly forward contracts (which during the nine months ended September 30, 2001 included allaccompanying March 31, 2002 Condensed Consolidated Balance Sheet. The closing of the Company’s material foreign subsidiaries). The Company does not use derivative financial instruments for trading or speculative purposes. The Company’s forward contracts do not subject itsale is expected to material risks due to exchange rate movements because gains and losses on these contracts are intended to offset exchange gains and losses on the underlying assets and liabilities; both the forward contracts and the underlying assets and liabilities are marked-to-market through earnings The aggregate foreign currency exchange gain/(loss) included in determining consolidated results of operations was approximately $105,000 and ($1,628,000), net of approximately ($530,000) and $460,000 of realized hedging (losses)/gains, which were recorded and included in other expense, net,take place in the three and nine months ended September 30, 2001, respectively.   Assecond quarter of September 30, 2001, there were no open forward contracts.2002.

9



Item 2. Management’sManagement's Discussion and Analysis of Financial Condition and Results of Operations.

Results of Operations.

Three Months Ended September 30,March 31, 2002 and 2001 and 2000

        

Net sales of $116.0$80.1 million for the three months ended September 30, 2001, represent an increaseMarch 31, 2002, represents a decrease of $34.9 million, or 43%,36% from the 20002001 comparable period net sales of $81.1$125.4 million, resulting principally from an increasereflecting a decrease in sales ofboth process equipment products.and metrology sales. Sales in the U.S., Europe, Japan and Asia Pacific, accounted for 51%55%, 22%14%, 18%17% and 9%14%, respectively, of the Company’sCompany's net sales for the three months ended September 30, 2001.March 31, 2002. Sales in the U.S. increased 38%decreased 40% from the comparable 20002001 period due to a 50% increase43% decline in U.S. process equipment sales, principally resulting from an increaseparticularly in sales intoof optical filter deposition products to the telecommunications industry, and a 31% decrease in U.S. metrology sales. This decrease in U.S. sales is offset in part by $9.3 million of sales of molecular beam epitaxy (MBE) equipment produced by Applied Epi, which was acquired in September 2001. Sales in Europe decreased 29% from the comparable 2001 period, due primarily to a decline in etch and deposition equipment sales to the data storage market.industry. Sales in Europe and Japan increased 73% and 129%, respectively. The increases in Europe and Japan are principally a result of higher sales of both process equipment and metrology products. Sales in Asia Pacific decreased by 30% over49% from the comparable 20002001 period principally as a result of a decline in processsales for both etch and deposition equipment sales.and atomic force microscopes (AFMs). Sales in Asia Pacific remained relatively flat from the comparable 2001 period. The Company believes that there will continue to be quarter-to-quarter variations in the geographic concentration of sales.

        

Process equipment sales of $65.9$44.8 million for the three months ended September 30, 2001, increased by $27.1March 31, 2002, represents a decrease of $35.5 million, or 70%44%, overfrom the comparable 2000 period. The increase2001 period, due primarily to an 88% decrease in process equipmentoptical filter deposition sales is due principally to increasedthe telecommunications industry, as well as a 30% decline in etch and deposition equipment sales, principally to the data storage industry. Metrology sales of $48.4$35.3 million for the three months ended September 30, 2001, represent an increase of approximately $8.6March 31, 2002 decreased by $9.8 million, or 22%, fromover the 2000 comparable period sales of $39.8 million. The increase in the 2001 period, isdue primarily attributable to increased sales of the Company’s atomic force microscope (AFM) products, offset partly by lowera 43% decline in sales of optical metrology products.products, as well as a 15% decrease in the sale of AFMs.

        

Veeco received $62.6$70.2 million of orders during the three months ended September 30, 2001,March 31, 2002, a 65%36% decrease compared to $179.9$110.2 million of orders for the comparable 20002001 period. Process equipment orders decreased 76%47% to $30.4$38.4 million, due primarily to a decline in orders from optical telecommunications customers. Orders for ion beam deposition products for optical filter manufacturing decreased by $80.6 million, or 95%, from the comparable 2000 period. Ion beam etch and deposition equipment orders, principally for data storage manufacturing, decreased 44% to $22.3 million from $40.1 million for the comparable 2000 period. Metrology orders decreased by 40% to $31.1 million, reflecting a decrease in orders for the telecommunications industry, as well as a decrease in orders for etch and deposition systems by data storage customers. Metrology orders decreased by 15% to $31.8 million, reflecting a decrease in bookings for both the Company's AFM and optical metrology line of products. The Company’s book/bill ratio for the thirdfirst quarter of 20012002 was 0.54.0.88.

        

ForThe order and sales declines are a result of the three months ended September 30, 2001,general economic slowdown that has had a very significant impact on the telecommunications, data storage and semiconductor markets that the Company experiencedserves.

        The Company's backlog generally consists of product orders for which a purchase order has been received and which are scheduled for shipment within twelve months. Veeco schedules production of its systems based on order backlog and customer commitments. Because certain of the Company's orders require products to be shipped in the same quarter in which the order was received, and due to possible changes in delivery schedules, cancellations primarily for products relatedof orders and delays in shipment, the Company does not believe that the level of backlog at any point in time is an accurate indicator of the Company's future performance. Due to the optical telecommunications market, representing approximately 26% of the June 30, 2001 backlog. The Company also experienced rescheduling of order delivery dates by customers. Due to thecurrent weak business environment, the Company may continue to experience cancellation and/or rescheduling of orders.

        

Gross profit for the three months ended March 31, 2002 of $33.7 million, represents a decrease of $25.0 million from the comparable 2001 period. Gross profit as a percentage of net sales decreased to 42.1% from 46.8% for the three months ended September 30,March 31, 2001, decreased to 43.8%, from 46.0%primarily as a result of the significant decline in sales volume for the comparable 2000 period.  The gross margin decline is attributable to a significant increase in automated AFM sales where 15% of revenue was deferred under SAB 101, until final customer acceptance.  Nearly all of this deferred revenue equates to profit, due to the fact that minimal related costs have been deferred.  During the same period in 2000, AFM sales consisted mostly of non-automated models, for which revenue recognition was not deferredboth process equipment and therefore higher profit margins were realized upon shipment.metrology.

10



Research and development expenses of $15.4$13.3 million for the three months ended September 30, 2001, increasedMarch 31, 2002, decreased by approximately $2.3$1.8 million, or 18%12%, over the comparable period of 2000, due primarily to2001. The decrease principally relates the Company’s developmentoverall decline in business and the cost reduction efforts taken by the Company during the fourth quarter of next generation products for ion beam deposition tools.2001, which included a 15% workforce reduction, plant consolidations, selective work-week reductions and reduced management salaries.

        

Selling, general and administrative expenses of $21.3$19.0 million for the three months ended September 30, 2001, increasedMarch 31, 2002, decreased by approximately $1.2$2.1 million, or 10%, over the comparable 2001 period. The decrease is due to decreased selling and commission expense related to the lower sales volume and the cost cutting measures mentioned above. The decrease in selling, general and administrative expenses is offset, in part, by $2.4 million of expenses from the 2000acquisitions of Applied Epi and ThermoMicroscopes ("TM"), which had no comparable periodspending in 2001.

        Amortization expense totaled $3.7 million in the first quarter of 2002 versus $1.4 million in 2001. The increase is due primarily to the intangible assets acquired in connection with the acquisitions of Applied Epi and TM, offset in part by $0.4 million of reduced amortization expense related to the accounting requirement to no longer amortize goodwill, effective January 1, 2002, in accordance with SFAS No. 142,Goodwill and Other Intangible Assets. Under SFAS No. 142, goodwill is to be reviewed annually for impairment. As of January 1, 2002, no impairment exists.

        Other expense decreased $1.4 million due to an increasea significant reduction in selling related expenses, principally as a resultforeign currency exchange losses, compared to the first quarter of the increased sales volume.2001.

        

During the three months ended September 30,March 31, 2002, the Company incurred a restructuring charge of $0.8 million related to the reduction in work force announced in the fourth quarter of 2001. This charge includes severance related costs for approximately 60 employees which included both management and manufacturing employees located at the Company's Minnesota, Plainview and Rochester operations. As of March 31, 2002, approximately $0.3 million has been expended and approximately $0.5 million remains accrued. During the year ended December 31, 2001, the Company recorded restructuring charges of approximately $20.0 million in response to the significant downturn in the telecommunications industry and the overall weak business environment. These charges consisted of a $13.6 million write-off of purchased in-process technologyinventory related to order cancellations and the rationalization of $8.2certain product lines, $3.0 million related to personnel and business relocation costs and $3.4 million related to the acquisitionswrite-down of Applied Epi, which resulted in a $7.0long-lived assets. The $3.0 million charge for personnel and TM, which resulted in a $1.2 million charge.  Both chargesbusiness relocation costs principally related to projects that had not reached technological feasibilityplant consolidations and had no alternative future uses.a workforce reduction of approximately 230 employees, which included both management and manufacturing employees located in all operations of the Company. As of March 31, 2002, approximately $1.7 million of the $3.0 million charge for relocation and termination benefits has been paid and approximately $1.3 million remains accrued.

        Interest expense, net of $1.5 million for the three months ended March 31, 2002 increased $2.3 million from the comparable 2001 period as a direct result of the issuance of $220.0 million of 4.125% convertible subordinated notes, which occurred in December 2001 and January 2002.

Income taxes for the three months ended September 30, 2001,March 31, 2002 amounted to $2.5a benefit of $1.6 million, or 57%34%, of incomeloss before income taxes, as compared to a $0.4 million tax benefit for the same period of 2000.  The effective tax rate of 57% is higher than the statutory tax rate of 35%, principally due to purchased in-process technology charges associated with the Applied Epi and TM acquisitions, which are non-deductible for tax purposes.

Effective January 1, 2000, the Company changed its method of accounting for revenue recognition in accordance with Staff Accounting Bulletin (SAB) No. 101, Revenue Recognition in Financial Statements, which resulted in a charge to income for the cumulative effect of change in accounting principle. The Company recognized approximately $5.8 million in revenue during the three months ended September 30, 2000, that was included in the cumulative effect adjustment. The effect of that revenue was to increase third quarter income by $1.8 million (net of income taxes of $1.3 million).

The financial information presented in the Company’s previously filed Form 10-Q, with respect to the three months ended September 30, 2000, has been restated due to the adoption of SAB 101. The adoption of SAB 101 had the overall effect of decreasing net sales and net income for the third quarter of 2000 by $11.8 million and $3.0 million, respectively, and basic and diluted earnings per share by $0.13 and $0.12, respectively.  These results include the impact of the cumulative effect adjustment discussed above.

Due to the weakening business environment, the Company is planning on implementing a cost reduction plan in the fourth quarter of 2001.  The Company plans a workforce reduction of approximately 15%, plant consolidations and discretionary cost reductions. The Company expects to record a restructuring charge in the fourth quarter of approximately $15.0 to $20.0 million associated with these actions.

Nine Months Ended September 30, 2001 and 2000

Net sales were $356.7 million for the nine months ended September 30, 2001, representing an increase of approximately $86.4$7.2 million, or 32%35%, over the comparable 2000 period. The increase is primarily due to an increase in optical filter deposition system sales of $47.4 million, as well as a $39.5 million increase in sales of AFMs. Sales in the U.S., Europe, Japan and Asia Pacific accounted for 56%, 15%, 20% and 9%, respectively, of the Company’s net sales for the nine months ended September 30, 2001. Sales in the U.S. increased by 54%, principally as a result of increased process equipment sales of optical telecommunications equipment, as well as an increase in sales of AFMs. Sales in Europe increased by 19% due to increased AFM sales.  Sales in Japan increased by 31% as a result of an increase in optical filter deposition and AFM sales. Asia Pacific sales decreased by 27% as a result of a 66% decline in optical metrology sales, partially offset by increased optical filter deposition equipment sales.

Process equipment sales were $219.4 million for the nine months ended September 30, 2001, an increase of approximately $67.7 million, or 45%, from the comparable 2000 period, due primarily to the increase in sales of optical filter deposition products. Metrology sales for the nine months ended September 30, 2001 were $132.3 million, an increase of approximately $21.8 million, or 20%, compared to the comparable 2000 period, reflecting a 64% increase in the sale of AFMs, offset by a 36% decline in optical metrology sales.


Veeco received $256.9 million of orders for the nine months ended September 30, 2001, a 39% decrease compared to $423.6 million of orders in the comparable 2000 period. Process equipment orders decreased 47% to $143.4 million, principally reflecting a decrease in optical telecommunications orders. Metrology orders decreased 25% to $108.5 million, reflecting a 56% decrease in optical metrology products. The book/bill ratio for the nine months ended September 30, 2001 was 0.72.

For the nine months ended September 30, 2001, the Company experienced order cancellations, primarily for products related to the optical telecommunications market, representing approximately 31% of the December 31, 2000 backlog. The Company also experienced rescheduling of order delivery dates by customers. Due to the weak business environment, the Company may continue to experience cancellation and/or rescheduling of orders.

Gross profit, as a percentage of net sales, increased slightly to 45.9% from 45.1% for the comparable 2000 period, which excludes a non-cash charge of $15.3 million for the write-off of inventory related to the merger with CVC in May 2000. This improvement is principally attributable to the sales volume increase in optical filter deposition products and AFMs.

Research and development expenses of $46.5 million for the nine months ended September 30, 2001, represent an increase of approximately $6.0 million, or 15%, over the comparable period of 2000, due primarily to the development of ion beam deposition and AFM products.

Selling, general and administrative expenses of $64.3 million for the nine months ended September 30, 2001, represent an increase of approximately $7.9 million, or 14%, over the comparable 2000 period. The increase is due to increased selling expense as a result of increased sales volume, primarily related to the optical filter deposition and AFM product lines. As a percentage of sales, selling, general and administrative expenses decreased to 18% of net sales in 2001 from 21% in 2000.

During the nine months ended September 30, 2001, the Company recorded a write-off of purchased in-process technology of $8.2 million, as discussed previously, and a restructuring charge of $1.0 million related to the workforce reduction of approximately 130 people, as a result of the slowdown in orders. As of September 30, 2001, approximately $765,000 has been expended and approximately $235,000 remains accrued, related to the restructuring charge. During the nine months ended September 30, 2000, Veeco incurred non-recurring charges of $33.0 million, in conjunction with the merger with CVC. Of these charges, a $15.3 million non-cash charge related to a write-off of inventory (included in cost of sales), $14.0 million represented merger and reorganization costs (of which $9.2 million related to transaction costs and $4.8 million pertained to duplicate facility and personnel costs) and $3.7 million was for the write-down of long-lived assets.

Other expense, net for the nine months ended September 30, 2001, increased $1.9 million over the comparable 2000 period due to the increase in foreign currency exchange losses.

Income taxes for the nine months ended September 30, 2001, amounted to $14.5 million, or 37% of income before income taxes, as compared to a $5.6 million income tax benefit, or 53% of loss before income taxes, for the same period of 2000.2001.

        Quarterly information for the three months ended March 31, 2001, has been restated from that previously filed on the Quarterly Report on Form 10-Q for such period, due to the required accounting for the discontinued operations of the Company's industrial measurement segment.

As noted above,Critical Accounting Policies

        General:    Veeco's discussion and analysis of its financial condition and results of operations are based upon Veeco's consolidated financial statements, which have been prepared in accordance with

11


accounting principles generally accepted in the United States. The preparation of these financial statements requires Veeco to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. On an on-going basis, management evaluates its estimates and judgments, including those related to derivatives, bad debts, inventories, intangible assets, income taxes, warranty obligations, restructuring costs and contingent litigation. Management bases its estimates and judgments on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. The Company considers certain accounting policies related to revenue recognition, the valuation of inventories, the impairment of goodwill and intangible assets and derivatives to be critical policies due to the estimation processes involved in each.

        Revenue Recognition:    The Company recognizes revenue when persuasive evidence of an arrangement exists, the seller's price is fixed or determinable and collectibility is reasonably assured. For products produced according to the Company's published specifications, where no installation is required or installation is deemed perfunctory and no substantive customer acceptance provisions exist, revenue is recognized when title passes to the customer, generally upon shipment. For products produced according to a particular customer's specifications, revenue is recognized when the product has been tested and it has been demonstrated that it meets the customer's specifications and title passes to the customer. The amount of revenue recorded is reduced by the amount of any customer retention (generally 10% to 20%), which is not payable by the customer until installation is completed and final customer acceptance is achieved. Installation is not deemed to be essential to the functionality of the equipment since installation does not involve significant changes to the features or capabilities of the equipment or building complex interfaces and connections. In addition, the equipment could be installed by the customer or other vendors and generally the cost of installation approximates only 1% to 2% of the sales value of the related equipment. For new applications of the Company's existing products, for new products or for products with substantive customer acceptance provisions where performance cannot be fully assessed prior to meeting customer specifications at the customer site, revenue is recognized upon completion of installation and receipt of final customer acceptance. Service and maintenance contract revenues are recorded as deferred revenue, which is included in other accrued expenses, and recognized as revenue on a straight-line basis over the service period of the related contract. The Company provides for warranty costs at the time the related revenue is recognized.

        Inventory Valuation:    Inventories are stated at the lower of cost (principally first-in, first-out method) or market. Management evaluates the need to record adjustments for impairment of inventory on a quarterly basis. The Company's policy is to assess the valuation of all inventories, including raw materials, work-in-progress, finished goods and spare parts. Obsolete inventory or inventory in excess of management's estimated usage for the next 18 to 24 month's requirements is written-down to its estimated market value, if less than its cost. Inherent in the estimates of market value are management's estimates related to Veeco's future manufacturing schedules, customer demand, technological and/or market obsolescence, possible alternative uses and ultimate realization of excess inventory.

        Goodwill and Intangible Asset Impairment:    The Company has significant intangible assets related to goodwill and other acquired intangibles. In assessing the recoverability of the Company's goodwill and other intangible assets, the Company changed its methodmust make assumptions regarding estimated future cash flows and other factors to determine the fair value of accountingthe respective assets. Changes in strategy and/or market conditions could significantly impact these assumptions, and thus Veeco may be required, during the annual review process, to record an impairment charge for revenue recognitionthese assets in accordance with SABSFAS No. 101. The cumulative effect of this change on prior years resulted in142.

12



        Derivatives:    During the deferral of $67.0 million of revenue and a charge to income of $18.4 million (net of income taxes of $12.6 million) recorded as of January 1, 2000, and is included in the Condensed Consolidated Statement of Operations for the ninethree months ended September 30, 2000. TheMarch 31, 2002, the Company recognized approximately $58.8 million of this deferred revenue during the nine months ended September 30, 2000. The effect of that revenue wasused derivative financial instruments to increase income in that period by $16.5 million (net of income taxes of $11.4 million).


The financial information presented in the Company’s previously filed Form 10-Q, with respect to the nine months ended September 30, 2000, has been restated due to the adoption of SAB 101. The adoption of SAB 101 had the overall effect of increasing net sales by $5.9 million for the nine months ended September 30, 2000. Net loss for that period increased by $16.6 million, and basic and diluted loss per share increased by $0.71.  These results includeminimize the impact of foreign exchange rate changes on earnings and cash flows. In the cumulativenormal course of business, operations are exposed to fluctuations in foreign exchange rates. In order to reduce the effect adjustment discussed above.

In June 2001,of fluctuating foreign currencies on short-term foreign currency-denominated intercompany transactions and other known foreign currency exposures, the FASB issued SFAS No. 141, Business Combinations,Company enters into monthly forward contracts (which during the three months ended March 31, 2002, included a majority of the Company's foreign subsidiaries). The Company does not use derivative financial instruments for trading or speculative purposes. The Company's forward contracts do not subject it to material risks due to exchange rate movements because gains and SFAS No. 142, Goodwilllosses on these contracts are intended to offset exchange gains and Other Intangible Assets, effective for fiscal years beginning after December 15, 2001. See Note 6 tolosses on the Condensed Consolidated Financial Statements above for additional disclosure, as tounderlying assets and liabilities; both the impact of these new rules.forward contracts and the underlying assets and liabilities are marked-to-market through earnings.

Liquidity and Capital Resources

        

Cash flows from operations were $13.4$1.8 million for the ninethree months ended September 30, 2001,March 31, 2002, as compared to $6.8$2.0 million for the comparable 20002001 period. Net income adjusted for non-cash items provided operating cash flows of $55.8$2.1 million for the ninethree months ended September 30, 2001March 31, 2002 compared to $27.4$24.7 million for the comparable 20002001 period. This increase inThe amount of net income adjusted for non-cash items for the three months ended March 31, 2002 was offset by increasesa decrease in working capital accounts of $21.8$0.3 million. Inventory balances increasedAccounts receivable for the three months ended March 31, 2002 decreased by $30.4$18.1 million, due primarily to rescheduled shipments andas a result of the impactdecrease in sales volume from the fourth quarter of SAB 101.2001. Deferred gross profit for the three months ended March 31, 2002 decreased by $9.3$5.3 million due toas a result of revenue recognition on tools that received final customer acceptance. Accounts receivableTaxes payable decreased by $17.9$8.1 million, dueas a result of income tax payments made by the Company's Japanese subsidiary and various other tax payments made in the first quarter of 2002 related to improved customer collections.sales and foreign taxes. In addition, accrued expenses decreased as a result of bonuses paid in the first quarter of 2002 and the decrease in accrued commission expense related to the decline in sales volume.

        In December 2001, the Company issued $200.0 million of 4.125% convertible subordinated notes, and in January 2002, the Company issued an additional $20.0 million of notes pursuant to an over allotment option.

        In connection with the subordinated notes issuance in December 2001 and January 2002, the Company purchased approximately $25.9 million of U.S. government securities, which have been pledged to the trustee under the indenture as security for the exclusive benefit of the holders of the notes. These securities will be sufficient to provide for the payment in full of the first six scheduled interest payments due on the notes and represent restricted investments.

Funds from operations the liquidation of short-term investments of $26.9 million and the borrowinguse of $25.0 million underproceeds received from the Facilityissuance of the subordinated note over allotment option in January 2002 were used to pay for capital expenditures and the scheduled repayment of long-term debt and acquisitions.debt.

        

On April 19, 2001, the Company entered into a new, $100 million revolving credit facility (the “Facility”), which replaced the Company’s prior $40 million revolving credit facility.  The Facility’s interest rate is a floating rate based on the prime rate of the lending banksAt March 31, 2002, Veeco's contractual cash obligations and is adjustablecommitments relating to a maximum rate of 1/4% above the prime rate in the event the Company’s ratio ofits debt to cash flow exceeds a defined ratio. A LIBOR based interest rate option is also provided. The Facility has a term of four yearsobligations and borrowings under the Facility may be used for general corporate purposes, including working capital and acquisitions. The Facility contains certain restrictive covenants, which among other things, impose limitations with respect to the incurrence of indebtedness, the payment of dividends, long-term leases, investments, mergers, acquisitions, consolidations and sales of assets. The Company is also required to satisfy certain financial tests. As of September 30, 2001, $25.0 million was outstanding under the Facility.lease payments are as follows (in thousands):

Contractual Obligations
 Total
 Less than 1 year
 1-3 years
 4-5 years
 After 5 years
Long-term debt $238,614 $3,458 $3,022 $1,261 $230,873
Operating leases  17,060  2,456  4,558  3,205  6,841
Letters of credit  3,971  3,971      
  
 
 
 
 
  $259,645 $9,885 $7,580 $4,466 $237,714
  
 
 
 
 

13


        

The Company believes that existing cash balances together with cash generated from operations and amounts available under the FacilityCompany's $100.0 million credit facility will be sufficient to meet the Company’sCompany's projected working capital and other cash flow requirements for the next twelve months.


Item 3. Quantitative and Qualitative Disclosure About Market Risk.

        

Veeco’sVeeco's net sales to foreign customers represented approximately 49% and 44%45% of Veeco’sVeeco's total net sales for the three and nine months ended September 30, 2001, respectively,March 31, 2002 and 47% and 53%41% for the three and nine months ended September 30, 2000, respectively.comparable 2001 period. The Company expects that net sales to foreign customers will continue to represent a large percentage of Veeco’sVeeco's total net sales. Veeco’sVeeco's net sales denominated in foreign currencies represented approximately 12% and 13%19% of Veeco’sVeeco's total net sales for the three and nine months ended September 30, 2001, respectively,March 31, 2002, and 13% and 10%15% for the three and nine months ended September 30, 2000, respectively.comparable 2001 period. The aggregate foreign currency exchange gain/(loss)loss included in determining consolidated results of operations was approximately $105,000immaterial during the three months ended March 31, 2002, and ($1,628,000),was $1.5 million, net of approximately ($530,000) and $460,000$0.9 million of realized hedging (losses)/gains which were recorded and included in other expense, net, inon forward exchange contracts, for the three and nine months ended September 30, 2001, respectively.March 31, 2001. The changeschange in currency exchange rates that have the largest impact on translating Veeco’sVeeco's international operating profit are the Japanese yenYen and the German mark.Euro. The Company estimates that based upon the September 30, 2001March 31, 2002 balance sheet, a 10% change in foreign currency exchange rates would impact reported operating profit by approximately $527,000.$1.4 million. The Company believes that this quantitative measure has inherent limitations because it does not take into account any governmental actions or changes in either customer purchasing patterns or financing and operating strategies. Veeco is exposed to financial market risks, including changes in foreign currency exchange rates. To mitigate these risks, commencing in March 2001, the Company began usingVeeco uses derivative financial instruments. Veeco does not use derivative financial instruments for speculative or trading purposes. The Company enters into monthly forward contracts to reduce the effect of fluctuating foreign currencies on short-term foreign currency-denominated intercompany transactions and other known currency exposures. The average notional amount of such contracts was approximately $2.5 million and $4.8$1.2 million for the three and nine months ended September 30, 2001, respectively.March 31, 2002. As of March 31, 2002, there were no open forward contracts.

14



PART II. OTHER INFORMATION

Part II.

Item 1. Legal Proceedings

The matters discussed above under Condensed Consolidated Financial Statements Note 5 - Recent Events - Litigation are hereby incorporated by reference.

Item 6. Exhibits and Reports on Form 8-K.

(a)
Exhibits

        

(a)  Exhibits

Unless otherwise indicated, each of the following exhibits has been previously filed with the Securities and Exchange Commission by the Company under File No. 0-16244.

Number


Exhibit


Incorporated by Reference to the Following Documents


2.1

10.1

Agreement and Plan of Merger,Third Amendment dated as of September 6, 2001, among Veeco Instruments Inc., Veeco Acquisition Corp., Applied Epi, Inc., the shareholders of Applied Epi, Inc. listed on the signature pages thereto and Paul E. Colombo, as Stockholders' Representative

Current Report on Form 8-K, filed on September 14, 2001, Exhibit 99.1

4.1

Amendment No. 1 dated July 26, 2001 to the Veeco Instruments Inc. 2000 Stock Option Plan for Non-Officer Employees

Registration Statement on Form S-8 (File Number 333-66574) filed on August 2, 2001, Exhibit 4.2

4.2

Amendment to Rights Agreement, dated as of September 6, 2001, between Veeco Instruments Inc. and American Stock Transfer and Trust Company, as rights agent

Current Report on Form 8-K, filed on September 21, 2001, Exhibit 4.1

4.3

Applied Epi, Inc. 1993 Stock Option Plan

Registration Statement on Form S-8 (File Number 333-69554) filed on September 18, 2001, Exhibit 4.1

4.4

Applied Epi, Inc. 2000 Stock Option Plan

Registration Statement on Form S-8 (File Number 333-69554) filed on September 18, 2001, Exhibit 4.2

4.5

Form of Applied Epi, Inc. Non-Qualified Restricted Stock Option Agreement

Registration Statement on Form S-8 (File Number 333-69554) filed on September 18, 2001, Exhibit 4.3

4.6

Form of Warrant to Purchase Shares of Common Stock of Applied Epi, Inc. (assumed in connection with the Applied Epi merger and now exercisable for shares of common stock of Veeco Instruments Inc.)

*

10.1

Amendment No. 1 dated as of September 17, 2001February 7, 2002 to the Credit Agreement, dated April 19, 2001 among Veeco Instruments Inc., Fleet National Bank, as administrative agent, The Chase Manhattan Bank, as syndication agent, HSBC Bank USA, as documentation agent and the lenders named therein

therein.

*

Annual Report on Form 10-K for the Year Ended December 31, 2001
Exhibit 10.4


10.2


10.2

Loan Agreement
Fourth Amendment dated as of December 15, 1999 between Applied Epi, Inc. and Jackson National Life Insurance Company

*

10.3

Promissory Note dated as of December 15, 1999 issued by Applied Epi, Inc. to Jackson National Life Insurance Company

*


(b)      Reports on Form 8-K.

On September 14, 2001, the Company filed a Current Report on Form 8-K regarding the signing of a merger agreement with Applied Epi, Inc.

On September 21, 2001, the Company filed a Current Report on Form 8-K regarding the closing of the merger with Applied Epi, Inc. and certain amendments to the Company’s Rights Plan (the “Form 8-K”).

On October 1, 2001, the Company filed an Amendment on Form 8-K/A to the Form 8-K, amending certain information in the Form 8-K.

On October 2, 2001, the Company filed an Amendment on Form 8-K/A to the Form 8-K, further amending certain information in the Form 8-K.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: November 13, 2001

Veeco Instruments Inc.

By:

/s/ Edward H. Braun

Edward H. Braun

Chairman, Chief Executive Officer and President

By:

/s/ John F. Rein, Jr.

John F. Rein, Jr.

Executive Vice President, Chief Financial Officer and Secretary


EXHIBIT INDEX

Unless otherwise indicated, each of the following exhibits has been previously filed with the Securities and Exchange Commission by the Company under File No. 0-16244.

Number

Exhibit

Incorporated by Reference to the Following Documents

2.1

Agreement and Plan of Merger, dated as of September 6, 2001, among Veeco Instruments Inc., Veeco Acquisition Corp., Applied Epi, Inc., the shareholders of Applied Epi, Inc. listed on the signature pages thereto and Paul E. Colombo, as Stockholders' Representative

Current Report on Form 8-K, filed on September 14, 2001, Exhibit 99.1

4.1

Amendment No. 1 dated July 26, 2001 to the Veeco Instruments Inc. 2000 Stock Option Plan for Non-Officer Employees

Registration Statement on Form S-8 (File Number 333-66574) filed on August 2, 2001, Exhibit 4.2

4.2

Amendment to Rights Agreement, dated as of September 6, 2001, between Veeco Instruments Inc. and American Stock Transfer and Trust Company, as rights agent

Current Report on Form 8-K, filed on September 21, 2001, Exhibit 4.1

4.3

Applied Epi, Inc. 1993 Stock Option Plan

Registration Statement on Form S-8 (File Number 333-69554) filed on September 18, 2001, Exhibit 4.1

4.4

Applied Epi, Inc. 2000 Stock Option Plan

Registration Statement on Form S-8 (File Number 333-69554) filed on September 18, 2001, Exhibit 4.2

4.5

Form of Applied Epi, Inc. Non-Qualified Restricted Stock Option Agreement

Registration Statement on Form S-8 (File Number 333-69554) filed on September 18, 2001, Exhibit 4.3

4.6

Form of Warrant to Purchase Shares of Common Stock of Applied Epi, Inc. (assumed in connection with the Applied Epi merger and now exercisable for shares of common stock of Veeco Instruments Inc.)

*

10.1

Amendment No. 1 dated as of September 17, 2001March 20, 2002 to the Credit Agreement, dated April 19, 2001 among Veeco Instruments Inc., Fleet National Bank, as administrative agent, The Chase Manhattan Bank, as syndication agent, HSBC Bank USA, as documentation agent and the lenders named therein

therein.


*


Annual Report on Form 10-K for the Year Ended December 31, 2001
Exhibit 10.5


10.3


10.2

Loan
Security Agreement dated as of December 15, 1999 between Applied Epi,March 20, 2002 among Veeco Instruments Inc., the subsidiaries of Veeco named therein and JacksonFleet National Life Insurance Company

Bank, as administrative agent.



*


*
Filed herewith

(b)
Reports on Form 8-K.

        None.

15



SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: May 9, 2002

Veeco Instruments Inc.




By:



/s/  
EDWARD H. BRAUN      

10.3

Promissory Note dated as of December 15, 1999 issued by Applied Epi, Inc. to Jackson National Life Insurance Company

*Edward H. Braun

Chairman, Chief Executive Officer and President



By:


/s/  
JOHN F. REIN, JR.      
John F. Rein, Jr.
Executive Vice President, Chief Financial Officer, Treasurer and Secretary


QuickLinks

SAFE HARBOR STATEMENT
INDEX
Veeco Instruments Inc. and Subsidiaries Condensed Consolidated Statements of Operations (In thousands, except per share data) (Unaudited)
Veeco Instruments Inc. and Subsidiaries Condensed Consolidated Balance Sheets (In thousands)
Veeco Instruments Inc. and Subsidiaries Condensed Consolidated Statements of Cash Flows (In thousands) (Unaudited)
SIGNATURES